MCM
RCKT icon

MAI Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

MAI Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.9K Buy
18,685
+14,320
+328% +$47.6K ﹤0.01% 1956
2026
Q1 		$15.6K Buy
4,365
+4,234
+3,232% +$16.8K ﹤0.01% 2927
2025
Q4 		$460 Buy
131
+29
+28% +$99 ﹤0.01% 3850
2025
Q3 		$333 Sell
102
-80
-44% -$252 ﹤0.01% 3663
2025
Q2 		$446 Buy
+182
New +$922 ﹤0.01% 3780

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

MAI Capital Management's RCKT Position: Q2 2026 in Review

MAI Capital Management increased its Rocket Pharmaceuticals (RCKT) stake by 328% in Q2 2026, buying an estimated $47.6K and bringing the position to 18,685 shares worth $63.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

MAI Capital Management first reported a position in RCKT in Q2 2025 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • MAI Capital Management held 18,685 shares of Rocket Pharmaceuticals worth $63.9K as of Q2 2026.
  • MAI Capital Management bought 14,320 Rocket Pharmaceuticals shares in Q2 2026, an estimated $47.6K.
  • Rocket Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1956 holding.
  • MAI Capital Management first reported a position in Rocket Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.